Partners Group Holding AG has selected banks for a potential initial public offering of Ammega Group BV as the private equity ...

Stada Arzneimittel AG’s private equity owners have selected bookrunners for a potential initial public offering of the ...

Buyout firm Advent International is considering the sale of generic drugmaker Zentiva, in a deal that could value the former Sanofi unit at about €5 billion ($5.4 billion), according to people ...

The new 100,000 sqm facility required an investment of around $75m. It has an annual production capacity of 150 million packs ...

A growing number of German firms are gearing up to go public in the coming months despite worries over Europe’s largest ...

STADA opens new production site & supply-chain hub in Turda, Romania with an investment of US$ 75 million: Bad Vilbel, ...

About AVT23 AVT23 is a monoclonal antibody and proposed biosimilar to Xolair ® (omalizumab). AVT23 is an investigational compound and has not received regulatory approval in any country. Biosimilarity ...

Huddersfield-based pharmaceutical leader STADA Thornton & Ross, part of the global STADA Group, has appointed Clare Furlonger ...

Stada Arzneimittel AG’s private equity owners have expanded the lineup to help lead a potential initial public offering of the German generic drugmaker, according to people familiar with the matter.

The U.S. Department of the Treasury said it has sanctioned Serbia-based Ventrade for providing Russia with advanced ...

The German group Stada announced it inaugurated a greenfield EUR 70 million factory in central Romania at Turda, where it ...

North Macedonia needs to continue to deliver on the implementation of EU-related reforms, in particular under the ...